Sinopharm Group Guangdong Hengxing Co., Ltd. announced that it will receive CNY 46,000,000 on April 19, 2017. The transaction will include participation from existing investor China National Accord Medicines Corporation Ltd. (SZSE:000028) to maintain its 100% stake in the company after the transaction. The registered capital of the company will increase from CNY 50,000,000 to CNY 96,000,000. The transaction was approved at the 22nd meeting of the 7th directorate of investor and does not need its shareholders’ approval. The company reported total assets of CNY 271,080,000, net assets of CNY 62,140,000, and revenue of CNY 1,505,160,000 for the year ended December 31, 2016.